Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
600
datasets available to search
ShareScore release 0.9.0
Dataset results
600 results for “Ophthalmitis”
3% Diquafosol Ophthalmic Solution for Active Moderate-to-Severe Vernal Keratoconjunctivitis
ClinicalTrials.gov study NCT06903884. IPD Sharing: Not stated. Countries: 0. Publications: 39.
Long-term Observation of Ophthalmic Changes in Patients With Obstructive Sleep Apnea
ClinicalTrials.gov study NCT03928665. IPD Sharing: NO. Countries: 1. Publications: 2.
Examining The Efficacy, Safety And Improved Tolerability Of Travoprost BAK Free Ophthalmic Solution (Travatan-Z) Compared To Prior Prostaglandin Therapy
ClinicalTrials.gov study NCT00444665. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Analysis of Ocular Complications of AIDS Patients in Ophthalmic Consultation
ClinicalTrials.gov study NCT06250881. IPD Sharing: UNDECIDED. Countries: 1. Publications: 5.
Phase II Clinical Study to Evaluate the Efficacy of Multidose Lagricel® Ofteno Ophthalmic Solution as Treatment for Dry Eye Disease.
ClinicalTrials.gov study NCT04704531. IPD Sharing: NO. Countries: 1. Publications: 0.
Efficacy and Safety Assessment of T4090 Ophthalmic Solution Versus Rhopressa® Ophthalmic Solution in Patients With Open-angle Glaucoma or Ocular Hypertension
ClinicalTrials.gov study NCT06394973. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Effects of a PF Ophthalmic Solution Containing HA0.4% and TAU 0.5%
ClinicalTrials.gov study NCT03480295. IPD Sharing: NO. Countries: 0. Publications: 1.
Safety and Efficacy of an Ophthalmic Solution in Dry Eye Disease
ClinicalTrials.gov study NCT00758784. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Bioequivalence Study With Clinical Endpoint Comparing Brinzolamide 1% Ophthalmic Suspension to Azopt® 1% Ophthalmic Suspension In the Treatment of Chronic Open Angle Glaucoma or Ocular Hypertension in
ClinicalTrials.gov study NCT02512042. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Confirm the Efficacy and Safety of K-161 Ophthalmic Solution for Treatment of Moderate to Severe Dry Eye Disease
ClinicalTrials.gov study NCT05403827. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Tear Fluid Levels of Loteprednol Etabonate Ophthalmic Gel 0.5% Following a Single Instillation
ClinicalTrials.gov study NCT01736527. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Mapracorat Ophthalmic Suspension, 3% for the Treatment of Ocular Inflammation Following Cataract Surgery
ClinicalTrials.gov study NCT01298752. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clinical Study for the Evaluation of Safety and Tolerability of PRO-172 Ophthalmic Solution+
ClinicalTrials.gov study NCT04693429. IPD Sharing: NO. Countries: 1. Publications: 0.
Assessment of the Safety and Efficacy Study of RGN-259 Ophthalmic Solutions for Neurotrophic Keratopathy : SEER-1
ClinicalTrials.gov study NCT02600429. IPD Sharing: NO. Countries: 1. Publications: 0.
Evaluating Safety and Efficacy of FID 112903 Post Discontinuation of Long-term Use of RESTASIS® (Cyclosporine Ophthalmic Emulsion) 0.05%
ClinicalTrials.gov study NCT01198782. IPD Sharing: Not stated. Countries: 0. Publications: 0.
Safety and Efficacy of Vancomycin Ophthalmic Ointment in Patients With Moderate to Severe Bacterial Conjunctivitis
ClinicalTrials.gov study NCT02432807. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Efficacy of Cyclosporine Ophthalmic Emulsion in Patients With Primary Pterygium
ClinicalTrials.gov study NCT01109056. IPD Sharing: Not stated. Countries: 3. Publications: 0.
Assessment of the Safety and Efficacy of RGN-259 Ophthalmic Solutions for Dry Eye Syndrome : ARISE-2
ClinicalTrials.gov study NCT02974907. IPD Sharing: NO. Countries: 1. Publications: 0.
Mapracorat Ophthalmic Suspension for the Treatment of Ocular Inflammation Following Cataract Surgery
ClinicalTrials.gov study NCT01230125. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Efficacy and Safety Study of OPC-1085EL Ophthalmic Solution in Subjects With Glaucoma or Ocular Hypertension
ClinicalTrials.gov study NCT02105272. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.